Diatos Gets $12.8M

Diatos, a French oncology drug developer, has accumulated EUR9.4m ($12.8 million) in a Series D financing round. Investors included AGF Private Equity, Biotech Fund Flanders, Credit Agricole Private Equity, GIMV, InterWest Partners, Innoven Partenaires, NIF SMBC Ventures, Societe Generale Asset Management, Sofinnova Partner and Sopartec. www.diatos.com